<DOC>
<DOCNO>
EP-0014425
</DOCNO>
<TEXT>
<DATE>
19800820
</DATE>
<IPC-CLASSIFICATIONS>
C07H-15/252 A61K-31/341 <main>C07H-15/24</main> C07H-15/00 A61K-31/70 C07D-307/20 C07D-307/00 A61P-35/00 A61K-31/34 
</IPC-CLASSIFICATIONS>
<TITLE>
anthracycline glycosides, methods for the production thereof and therapeutical compositions containing same.
</TITLE>
<APPLICANT>
erba farmitaliait   <sep>farmitalia carlo erba s.p.a.<sep>farmitalia carlo erba s.p.a.via carlo imbonati, 24i-20159 milanoit<sep>farmitalia carlo erba s.p.a.<sep>
</APPLICANT>
<INVENTOR>
arcamone federico<sep>cassinelli guiseppe<sep>di marco aurelio dr<sep>arcamone, federico<sep>cassinelli, guiseppe<sep>di marco, aurelio, dr.<sep>arcamone, federicovia 4 novembre n. 26nerviano (milano)it<sep>cassinelli, guiseppevia g. matteotti n. 13voghera (pavia)it<sep>di marco, aurelio, dr.via plinio n. 59milanoit<sep>arcamone, federico<sep>cassinelli, guiseppe<sep>di marco, aurelio, dr. <sep>arcamone, federico via 4 novembre n. 26 nerviano (milano)it<sep>cassinelli, guiseppevia g. matteotti n. 13voghera (pavia)it<sep>di marco, aurelio, dr.via plinio n. 59milanoit<sep>
</INVENTOR>
<ABSTRACT>
compounds which in form of pharmaceutical prepara­ tions have an antitumor activity higher or comparable to  those of conventional drugs, e. g.  daunorubicin and dox­ orubicin.  the compounds are of the formula    wherein one of r₁ and r₂ represents a hydrogen atom, the  other of r₁ and r₂ represents a formyl, hydroxymethyl or  aminomethyl group, and r₃ represents a hydrogen atom or a  hydroxy or acyloxy group, and pharmaceutically acceptable  acid addition salts of such compounds in which one of r₁ and  r₂ represents an aminomethyl group, methods for prepara­ tion of said compounds and therapeutical compositions con­ taining same.  
</ABSTRACT>
</TEXT>
</DOC>
